Atlas Venture Associates Opportunity I, LLC
10% owner at Kymera Therapeutics; 10% owner at Disc Medicine.
- Rank
- 213th of 809
- Companies held
- 2
- Largest holding
- KYMR, 76.2% of total
- Latest SEC filing
- Mar 13, 2024
- Listed but not counted
- $164M
What the $732M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kymera Therapeutics KYMR Common Stock | Directly | 4,676,075 | $119.39 | $558M | 76.2% | Form 4, Mar 13, 2024 |
| Disc Medicine IRON Common Stock | Directly | 1,479,686 | $76.11 | $113M | 15.4% | Form 4, Dec 14, 2023 |
| Disc Medicine IRON Common Stock | Indirectly (see filing footnote) | 806,160 | $76.11 | $61.4M | 8.4% | Form 4, Dec 14, 2023 |
Share counts are the amounts Atlas Venture Associates Opportunity I, LLC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Atlas Venture Associates Opportunity I, LLC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kymera Therapeutics KYMR Common Stock | Through Atlas Venture Opportunity Fund I, L.P. Held by a company or fund the insider manages | 828,830 | $119.39 | $99.0M | — | Form 4, Mar 13, 2024 |
| Disc Medicine IRON Common Stock | Through Atlas Venture Opportunity Fund I, L.P. Held by a company or fund the insider manages | 855,471 | $76.11 | $65.1M | — | Form 4, Dec 12, 2023 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 210 | Lion Fund Ii, L.P. 10% owner, Biglari Holdings | $743M |
| 211 | Schlumberger Limited/nv 10% owner, Liberty Energy | $736M |
| 212 | NAVER Corp 10% owner, WEBTOON Entertainment | $733M |
| 213 | Atlas Venture Associates Opportunity I, LLC 10% owner, Kymera Therapeutics | $732M |
| 214 | EdgePoint Investment Group Inc. Director, Mattel | $727M |
| 215 | Series U of UM Partners, LLC 10% owner, Utz Brands | $723M |
| 216 | Abrams Capital Management, LLC 10% owner, Loar Holdings | $721M |
Other Kymera Therapeutics insiders
All KYMR insiders- Nello Mainolfi$79.6MChief Executive Officer. #1805 overall
- Bruce N. Jacobs$29.2MChief Financial Officer. #3859 overall
- Jared Gollob$14.0MChief Medical Officer. #6806 overall
- Ellen Chiniara$9.6MChief Legal Officer. #9086 overall
- Brian Adams$6.0MChief Legal Officer. #7698 overall
- Noah Goodman$5.6MChief Business Officer. #13327 overall
Questions
How much stock does Atlas Venture Associates Opportunity I, LLC own?
Atlas Venture Associates Opportunity I, LLC holds $732,252,333 in listed stock based on SEC filings and current prices, mostly Kymera Therapeutics (KYMR). That ranks 213th on the Stock Rich List.
Is this Atlas Venture Associates Opportunity I, LLC's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.